Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New school program aims to get kids with asthma moving more

NCT ID NCT04576442

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a school-based program called Asthma-PASS to help children with asthma be more physically active. The program worked with doctors, community health workers, and schools to ensure kids had the right medications and could use rescue inhalers at school. Researchers measured symptom-free days and physical activity levels in 452 children to see if the program made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Asthma-PASS (behavioral intervention: coordination with primary care providers, community health worker support, and medication management at school)
What this could lead to
If successful, this program could help urban children with asthma be more physically active and have fewer symptom days, improving their quality of life.
What could go wrong
This is a completed study, so results are available but may not apply to all children or settings. The program relies on school and healthcare system cooperation, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

452 people

The number who actually took part.

Started

Feb 2021

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Physician-diagnosed asthma (based on parent report with validation from the child's physician) * Intermittent asthma (but with a report of asthma symptoms, such as coughing, wheezing, chest tightness, mucus/phlegm or shortness of breath, in the past 12 months) * Mild persistent or more severe asthma based on prescribed controller medication (currently well-controlled) but with a report of asthma symptoms (as specified above) within the past 12 months \[well-controlled due to taking controller medications in the past 12 months and without asthma symptoms (as specified above) within the past 12 months will qualify\] * Mild persistent or more severe asthma, or asthma that is uncontrolled despite therapy (based on age-specific guidelines) * Attending pre-kindergarten through 5th grade in NYC (primarily Bronx) schools and also schools in lower Hudson Valley * Parent is able to speak and understand either English or Spanish * Consent from the primary caregiver, caregiver permission for child participation as well as assent from the child (for age 7 and above) Exclusion Criteria: * No access to a phone to conduct follow-up surveys * Family plans to leave the school or city in less than 6 months * The child has other significant medical conditions, such as congenital heart disease, cystic fibrosis, or other chronic lung disease * Child is unable to participate in routine physical education (PE) classes as per physician-completed sports participation form * Children in foster care or other situations in which consent cannot be obtained from a guardian * Child is a participant in a concurrent asthma intervention study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma in children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital at Montefiore, Albert Einstein College of Medicine

    The Bronx, New York, 10467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.